Novel corona virus disease (COVID‐19) in pregnancy: What clinical recommendations to follow?

  title={Novel corona virus disease (COVID‐19) in pregnancy: What clinical recommendations to follow?},
  author={Huan Liang and Ganesh Acharya},
  journal={Acta Obstetricia et Gynecologica Scandinavica},
Pregnancy is a state of partial immune suppression which makes pregnant women more vulnerable to viral infections, and the morbidity is higher even with seasonal influenza. Therefore, the COVID19 epidemic may have serious consequences for pregnant women. Although the vast majority of cases of COVID-19 are currently in China, the risk of outward transmission appears to be significantly raising global concern. Human to human transmission of the virus is proven to occur,1,2 perhaps even from… 

Topics from this paper

Paper Mentions

Interventional Clinical Trial
Mental health disorders are common during pregnancy and the postnatal period, and can have serious adverse effects on the well-being of woman and child. Every tenth woman has… 
ConditionsAnxiety, COVID19, Perinatal Depression, (+2 more)
Observational Clinical Trial
Currently there is a great need for an accurately and rapid assessment of patients suspected for Covid-19. Like CT, Lung Ultrasound (LUS) examination can potentially help with the… 
ConditionsCOVID, Diagnoses Disease, Pneumonia, (+5 more)
InterventionDiagnostic Test
Preventive measures and management of COVID-19 in pregnancy
This commentary reviews the available information on managing COVID-19 during pregnancy to preserve the health of mothers and children in this critical situation.
Relationship of COVID-19 with pregnancy
  • U. Salma
  • Medicine
    Taiwanese Journal of Obstetrics and Gynecology
  • 2021
Repeated testing, contact tracing and self-isolation will assist to control the spread of SARS-CoV2 infection and CO VID-19 disease until specific vaccine and pharmaceuticals drugs of COVID-19 are available.
A comprehensive review: Coronavirus disease 2019 (COVID-19)
In March 2020 the World Health Organization described the SARS-Cov-2 virus as global pandemic. In the whole world, confirmed cases and death rate are increasing in exponential way. SARS-Cov-2 belong
Management of SARS-CoV-2 infection in pregnancy
The SARS-CoV-2 infection, which originated from a market in Wuhan, China, spread rapidly, so on March 11, 2020, the WHO decreed that the outbreak became a pandemic. Over 90% of people infected with
COVID-19 in pregnant women
World Health Organization (WHO) suggests that there is no specific evidence exists that pregnant women are more prone to severe COVID-19 symptoms than other general people.
COVID-19: neonatal–perinatal perspectives
This review provides a comprehensive overview of neonatal–perinatal perspectives of COVID-19, ranging from the basic science of infection and recommendations for care of pregnant women and neonates to important psychosocial, ethical, and racial/ethnic topics emerging as a result of both the pandemic and the response of the healthcare community to the care of infected individuals.
A picture of the covid-19 impact on IVIRMA fertility treatment clinics in Spain and Italy
Abstract The emergence of the novel coronavirus infection that arose in Wuhan, China in December 2019 has resulted in an epidemic that has quickly expanded to become one of the most significant
COVID-19 and pregnant women - An overview on diagnosis, treatment approach with limitation, and clinical management.
A review of signs and symptoms, etiopathogenesis, risk factors, diagnosis, and possible management of COVID-19 infection in pregnant women for health care providers for practical approach and limitation of drugs used in the current management.
COVID-19 and the cardiovascular system in pregnancy
Pregnancy and coronavirus disease-2019 (COVID-19) share several common features which makes differentiation between the 2 difficult, suggesting that pregnant patients with more severe disease courses may be over-represented in the current literature, particularly the early case reports and case series.
A review of initial data on pregnancy during the COVID-19 outbreak: implications for assisted reproductive treatments
The current outbreak of the novel 2019 coronavirus disease (COVID-19) started in China in December 2019 and has since spread to several other countries. On March 25, 2020, a total of 375,498 cases


Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records
There is currently no evidence for intrauterine infection caused by vertical transmission in women who develop COVID-19 pneumonia in late pregnancy, according to this small group of cases.
Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
This study evaluated the antiviral efficiency of five FAD-approved drugs including ribavirin, penciclovir, nitazoxanide, nafamostat, chloroquine and two well-known broad-spectrum antiviral drugs remdesivir and favipiravir against a clinical isolate of 2019-nCoV in vitro.
Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia
There is evidence that human-to-human transmission has occurred among close contacts since the middle of December 2019 and considerable efforts to reduce transmission will be required to control outbreaks if similar dynamics apply elsewhere.
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study
Characteristics of patients who died were in line with the MuLBSTA score, an early warning model for predicting mortality in viral pneumonia, and further investigation is needed to explore the applicability of the Mu LBSTA scores in predicting the risk of mortality in 2019-nCoV infection.
Clinical analysis of 10 neonates born to mothers with 2019-nCoV pneumonia.
Perinatal 2019-nCoV infection may have adverse effects on newborns, causing problems such as fetal distress, premature labor, respiratory distress, thrombocytopenia accompanied by abnormal liver function, and even death.
Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention.
Background: Hospitalised COVID-19 patients are frequently elderly subjects with co-morbidities receiving polypharmacy, all of which are known risk factors for d
A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster
The findings are consistent with person-to-person transmission of this novel coronavirus in hospital and family settings, and the reports of infected travellers in other geographical regions.
The Novel Coronavirus Originating in Wuhan, China: Challenges for Global Health Governance.
The current status of 2019-nCoV, the response, and proposals for bringing the outbreak under control are described and offered.
Correlation of Chest CT and RT-PCR Testing in Coronavirus Disease 2019 (COVID-19) in China: A Report of 1014 Cases
Chest CT has a high sensitivity for diagnosis of CO VID-19 and may be considered as a primary tool for the current COVID-19 detection in epidemic areas, as well as for patients with multiple RT-PCR assays.
What are the risks of COVID-19 infection in pregnant women?
This research explores the choice and number of gene targets on the nucleic acid targets in the nucleus and investigates the ability of these targets to be targeted by the immune system.